ZA200203628B - Method for the stereoselective synthesis of cyclic amino acids. - Google Patents

Method for the stereoselective synthesis of cyclic amino acids. Download PDF

Info

Publication number: ZA200203628B
Authority: ZA; South Africa
Prior art keywords: formula; produce; mixture; product; stirring
Prior art date: 1999-12-08

Application number

ZA200203628A

Other languages

English (en)

Inventor

Justin Stephen Bryans

Sophie Caroline Williams

David Clive Blakemore

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-08

Filing date

2002-05-07

Publication date

2003-08-07

2002-05-07 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2003-08-07 Publication of ZA200203628B publication Critical patent/ZA200203628B/en

Links

238000000034 method Methods 0.000 title claims description 54
-1 cyclic amino acids Chemical class 0.000 title claims description 20
230000015572 biosynthetic process Effects 0.000 title description 5
238000003786 synthesis reaction Methods 0.000 title description 5
230000000707 stereoselective effect Effects 0.000 title description 2
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 216
239000000203 mixture Substances 0.000 claims description 216
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 153
239000002904 solvent Substances 0.000 claims description 144
238000003756 stirring Methods 0.000 claims description 142
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 138
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 136
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 126
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 118
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 103
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 102
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 89
150000001875 compounds Chemical class 0.000 claims description 87
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 84
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 81
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 78
229910052739 hydrogen Inorganic materials 0.000 claims description 76
150000003839 salts Chemical class 0.000 claims description 76
125000000217 alkyl group Chemical group 0.000 claims description 62
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 60
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 59
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 58
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 57
150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 57
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 56
230000008569 process Effects 0.000 claims description 50
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 49
WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 48
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 48
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 46
BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 claims description 44
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 40
150000002148 esters Chemical class 0.000 claims description 40
125000000753 cycloalkyl group Chemical group 0.000 claims description 39
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 37
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 36
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 33
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 32
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 32
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 32
MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 claims description 30
239000012948 isocyanate Substances 0.000 claims description 30
238000010992 reflux Methods 0.000 claims description 30
239000002253 acid Substances 0.000 claims description 29
150000002513 isocyanates Chemical class 0.000 claims description 29
ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 claims description 28
150000001412 amines Chemical class 0.000 claims description 27
238000002360 preparation method Methods 0.000 claims description 26
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 25
GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 claims description 24
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 24
150000001735 carboxylic acids Chemical class 0.000 claims description 24
MLIREBYILWEBDM-UHFFFAOYSA-M 2-cyanoacetate Chemical compound [O-]C(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-M 0.000 claims description 22
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 21
238000006000 Knoevenagel condensation reaction Methods 0.000 claims description 21
150000001336 alkenes Chemical class 0.000 claims description 21
239000007809 chemical reaction catalyst Substances 0.000 claims description 21
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 20
239000008096 xylene Substances 0.000 claims description 20
150000003738 xylenes Chemical class 0.000 claims description 20
SCEZYJKGDJPHQO-UHFFFAOYSA-M magnesium;methanidylbenzene;chloride Chemical compound [Mg+2].[Cl-].[CH2-]C1=CC=CC=C1 SCEZYJKGDJPHQO-UHFFFAOYSA-M 0.000 claims description 19
SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 18
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 18
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 17
YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 claims description 16
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 16
MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 claims description 15
FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 15
BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 15
YTAHJIFKAKIKAV-XNMGPUDCSA-N [(1R)-3-morpholin-4-yl-1-phenylpropyl] N-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamate Chemical compound O=C1[C@H](N=C(C2=C(N1)C=CC=C2)C1=CC=CC=C1)NC(O[C@H](CCN1CCOCC1)C1=CC=CC=C1)=O YTAHJIFKAKIKAV-XNMGPUDCSA-N 0.000 claims description 15
IYGZPNSIEQRRIL-UHFFFAOYSA-M [I-].[Mg+]CC1=CC=CC=C1 Chemical compound [I-].[Mg+]CC1=CC=CC=C1 IYGZPNSIEQRRIL-UHFFFAOYSA-M 0.000 claims description 15
HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 claims description 15
RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 claims description 15
WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 claims description 14
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 14
PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 claims description 12
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 12
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 12
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 12
PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 claims description 12
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 11
239000005695 Ammonium acetate Substances 0.000 claims description 11
OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 claims description 11
229940043376 ammonium acetate Drugs 0.000 claims description 11
235000019257 ammonium acetate Nutrition 0.000 claims description 11
238000010438 heat treatment Methods 0.000 claims description 11
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 11
QGEFGPVWRJCFQP-UHFFFAOYSA-M magnesium;methanidylbenzene;bromide Chemical compound [Mg+2].[Br-].[CH2-]C1=CC=CC=C1 QGEFGPVWRJCFQP-UHFFFAOYSA-M 0.000 claims description 11
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 11
DHCWLIOIJZJFJE-UHFFFAOYSA-L dichlororuthenium Chemical compound Cl[Ru]Cl DHCWLIOIJZJFJE-UHFFFAOYSA-L 0.000 claims description 10
150000003512 tertiary amines Chemical class 0.000 claims description 10
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 9
NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 claims description 8
YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 claims description 8
RQEUFEKYXDPUSK-SSDOTTSWSA-N (1R)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-SSDOTTSWSA-N 0.000 claims description 7
238000002955 isolation Methods 0.000 claims description 7
RTCUCQWIICFPOD-SECBINFHSA-N (1r)-1-naphthalen-1-ylethanamine Chemical compound C1=CC=C2C([C@H](N)C)=CC=CC2=C1 RTCUCQWIICFPOD-SECBINFHSA-N 0.000 claims description 6
RTCUCQWIICFPOD-VIFPVBQESA-N (1s)-1-naphthalen-1-ylethanamine Chemical compound C1=CC=C2C([C@@H](N)C)=CC=CC2=C1 RTCUCQWIICFPOD-VIFPVBQESA-N 0.000 claims description 6
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 6
XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 claims description 6
BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 claims description 6
XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 claims description 6
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 6
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
238000010533 azeotropic distillation Methods 0.000 claims description 6
FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 6
229910000024 caesium carbonate Inorganic materials 0.000 claims description 6
SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 claims description 6
238000001035 drying Methods 0.000 claims description 6
238000001704 evaporation Methods 0.000 claims description 6
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 6
229960004592 isopropanol Drugs 0.000 claims description 6
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 6
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 6
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 6
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical class [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 6
238000000638 solvent extraction Methods 0.000 claims description 6
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 5
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 5
YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 claims description 5
RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 claims description 4
GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims description 4
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 4
229910000041 hydrogen chloride Inorganic materials 0.000 claims description 4
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 2
239000001117 sulphuric acid Substances 0.000 claims description 2
235000011149 sulphuric acid Nutrition 0.000 claims description 2
239000000047 product Substances 0.000 claims 225
229960000583 acetic acid Drugs 0.000 claims 49
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims 10
CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims 8
230000003301 hydrolyzing effect Effects 0.000 claims 6
150000007513 acids Chemical class 0.000 claims 5
VNEBWJSWMVTSHK-UHFFFAOYSA-L disodium;3-hydroxynaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=CC2=C1 VNEBWJSWMVTSHK-UHFFFAOYSA-L 0.000 claims 5
230000007062 hydrolysis Effects 0.000 claims 5
238000006460 hydrolysis reaction Methods 0.000 claims 5
239000012044 organic layer Substances 0.000 claims 5
GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 claims 5
SCZNXLWKYFICFV-UHFFFAOYSA-N 1,2,3,4,5,7,8,9-octahydropyrido[1,2-b]diazepine Chemical compound C1CCCNN2CCCC=C21 SCZNXLWKYFICFV-UHFFFAOYSA-N 0.000 claims 4
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims 4
150000003939 benzylamines Chemical class 0.000 claims 4
239000013067 intermediate product Substances 0.000 claims 4
ADWIWXOZYGYVBT-JXLXBRSFSA-N 2-[(1s,3r)-1-(aminomethyl)-3-methylcyclopentyl]acetic acid;hydrochloride Chemical compound Cl.C[C@@H]1CC[C@@](CN)(CC(O)=O)C1 ADWIWXOZYGYVBT-JXLXBRSFSA-N 0.000 claims 3
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 3
LRHPLDYGYMQRHN-UHFFFAOYSA-N butyl alcohol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 3
229910052700 potassium Inorganic materials 0.000 claims 3
239000011591 potassium Substances 0.000 claims 3
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 2
WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 claims 2
RSGLEFABCXIVCD-LDYMZIIASA-N 2-[(1r,3r)-1-(2-methoxy-2-oxoethyl)-3-methylcyclopentyl]acetic acid Chemical compound COC(=O)C[C@]1(CC(O)=O)CC[C@@H](C)C1 RSGLEFABCXIVCD-LDYMZIIASA-N 0.000 claims 1
ADWIWXOZYGYVBT-PRCZDLBKSA-N 2-[(1r,3r)-1-(aminomethyl)-3-methylcyclopentyl]acetic acid;hydrochloride Chemical compound Cl.C[C@@H]1CC[C@](CN)(CC(O)=O)C1 ADWIWXOZYGYVBT-PRCZDLBKSA-N 0.000 claims 1
ICPGNFMQMYVJQG-DOMZBBRYSA-N 2-[(1s,3r)-1-benzyl-3-methylcyclopentyl]acetic acid Chemical compound C1[C@H](C)CC[C@@]1(CC(O)=O)CC1=CC=CC=C1 ICPGNFMQMYVJQG-DOMZBBRYSA-N 0.000 claims 1
JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 claims 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
101100440696 Caenorhabditis elegans cor-1 gene Proteins 0.000 claims 1
230000003197 catalytic effect Effects 0.000 claims 1
YQSCEWPODVBHBY-KGSKPCQNSA-N ethyl (2e)-2-cyano-2-[(3r)-3-methylcyclopentylidene]acetate Chemical compound CCOC(=O)C(\C#N)=C1/CC[C@@H](C)C1 YQSCEWPODVBHBY-KGSKPCQNSA-N 0.000 claims 1
YQSCEWPODVBHBY-SREPSJJZSA-N ethyl (2z)-2-cyano-2-[(3r)-3-methylcyclopentylidene]acetate Chemical compound CCOC(=O)C(\C#N)=C1\CC[C@@H](C)C1 YQSCEWPODVBHBY-SREPSJJZSA-N 0.000 claims 1
FDHSIUKPLHGPRQ-BXKDBHETSA-N methyl 2-[(1r,3r)-1-[(methoxycarbonylamino)methyl]-3-methylcyclopentyl]acetate Chemical compound COC(=O)NC[C@]1(CC(=O)OC)CC[C@@H](C)C1 FDHSIUKPLHGPRQ-BXKDBHETSA-N 0.000 claims 1
YTLLROYGPGMQCR-KOLCDFICSA-N methyl 2-[(1s,3r)-1-(isocyanatomethyl)-3-methylcyclopentyl]acetate Chemical compound COC(=O)C[C@]1(CN=C=O)CC[C@@H](C)C1 YTLLROYGPGMQCR-KOLCDFICSA-N 0.000 claims 1
FDHSIUKPLHGPRQ-SKDRFNHKSA-N methyl 2-[(1s,3r)-1-[(methoxycarbonylamino)methyl]-3-methylcyclopentyl]acetate Chemical compound COC(=O)NC[C@@]1(CC(=O)OC)CC[C@@H](C)C1 FDHSIUKPLHGPRQ-SKDRFNHKSA-N 0.000 claims 1
XCTYFGVRVDPWJD-CJNGLKHVSA-N methyl 2-[(1s,3r)-1-benzyl-3-methylcyclopentyl]acetate Chemical compound C=1C=CC=CC=1C[C@]1(CC(=O)OC)CC[C@@H](C)C1 XCTYFGVRVDPWJD-CJNGLKHVSA-N 0.000 claims 1
150000004702 methyl esters Chemical class 0.000 claims 1
229910052938 sodium sulfate Inorganic materials 0.000 claims 1
235000011152 sodium sulphate Nutrition 0.000 claims 1
239000001257 hydrogen Substances 0.000 description 10
UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 description 9
150000002431 hydrogen Chemical class 0.000 description 6
125000003545 alkoxy group Chemical group 0.000 description 4
229910052794 bromium Inorganic materials 0.000 description 4
239000000460 chlorine Substances 0.000 description 4
229910052731 fluorine Inorganic materials 0.000 description 4
229960002870 gabapentin Drugs 0.000 description 4
125000003342 alkenyl group Chemical group 0.000 description 3
125000000304 alkynyl group Chemical group 0.000 description 3
206010015037 epilepsy Diseases 0.000 description 3
229910052736 halogen Inorganic materials 0.000 description 3
150000002367 halogens Chemical class 0.000 description 3
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
101500028027 Mus musculus Cathelin-related antimicrobial peptide Proteins 0.000 description 2
150000001413 amino acids Chemical class 0.000 description 2
150000001540 azides Chemical class 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
229910052801 chlorine Inorganic materials 0.000 description 2
238000011109 contamination Methods 0.000 description 2
125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
239000000543 intermediate Substances 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
XQFGVGNRDPFKFJ-UHFFFAOYSA-N 1,2,3,5,6,7-hexahydropyrrolo[1,2-b]pyridazine Chemical compound N1CCC=C2CCCN21 XQFGVGNRDPFKFJ-UHFFFAOYSA-N 0.000 description 1
SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
208000018152 Cerebral disease Diseases 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
102000002045 Endothelin Human genes 0.000 description 1
108050009340 Endothelin Proteins 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
208000006083 Hypokinesia Diseases 0.000 description 1
CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
GUDBSTJKAWCJQP-UHFFFAOYSA-N [Mg]CC1=CC=CC=C1 Chemical compound [Mg]CC1=CC=CC=C1 GUDBSTJKAWCJQP-UHFFFAOYSA-N 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
230000001773 anti-convulsant effect Effects 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
229960003965 antiepileptics Drugs 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052792 caesium Inorganic materials 0.000 description 1
TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
230000002490 cerebral effect Effects 0.000 description 1
FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
208000002173 dizziness Diseases 0.000 description 1
230000000694 effects Effects 0.000 description 1
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 description 1
230000003483 hypokinetic effect Effects 0.000 description 1
125000002632 imidazolidinyl group Chemical group 0.000 description 1
125000002883 imidazolyl group Chemical group 0.000 description 1
230000006872 improvement Effects 0.000 description 1
125000001041 indolyl group Chemical group 0.000 description 1
208000014674 injury Diseases 0.000 description 1
239000011630 iodine Substances 0.000 description 1
125000001786 isothiazolyl group Chemical group 0.000 description 1
125000000842 isoxazolyl group Chemical group 0.000 description 1
125000002757 morpholinyl group Chemical group 0.000 description 1
125000001624 naphthyl group Chemical group 0.000 description 1
229940072228 neurontin Drugs 0.000 description 1
125000001715 oxadiazolyl group Chemical group 0.000 description 1
125000000160 oxazolidinyl group Chemical group 0.000 description 1
125000002971 oxazolyl group Chemical group 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229960005152 pentetrazol Drugs 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
125000004193 piperazinyl group Chemical group 0.000 description 1
125000003386 piperidinyl group Chemical group 0.000 description 1
125000003226 pyrazolyl group Chemical group 0.000 description 1
125000004076 pyridyl group Chemical group 0.000 description 1
125000000714 pyrimidinyl group Chemical group 0.000 description 1
125000000168 pyrrolyl group Chemical group 0.000 description 1
YAYGSLOSTXKUBW-UHFFFAOYSA-N ruthenium(2+) Chemical compound [Ru+2] YAYGSLOSTXKUBW-UHFFFAOYSA-N 0.000 description 1
150000003536 tetrazoles Chemical class 0.000 description 1
125000003831 tetrazolyl group Chemical group 0.000 description 1
125000001113 thiadiazolyl group Chemical group 0.000 description 1
125000001984 thiazolidinyl group Chemical group 0.000 description 1
125000000335 thiazolyl group Chemical group 0.000 description 1
125000001544 thienyl group Chemical group 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000008733 trauma Effects 0.000 description 1
125000001425 triazolyl group Chemical group 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C07C227/32—Preparation of optical isomers by stereospecific synthesis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C265/00—Derivatives of isocyanic acid
- C07C265/02—Derivatives of isocyanic acid having isocyanate groups bound to acyclic carbon atoms
- C07C265/06—Derivatives of isocyanic acid having isocyanate groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C265/08—Derivatives of isocyanic acid having isocyanate groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/608—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a ring other than a six-membered aromatic ring in the acid moiety
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
- C07C69/616—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety polycyclic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Neurology (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Crystallography & Structural Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

ZA200203628A 1999-12-08 2002-05-07 Method for the stereoselective synthesis of cyclic amino acids. ZA200203628B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US16960299P	1999-12-08	1999-12-08

Publications (1)

Publication Number	Publication Date
ZA200203628B true ZA200203628B (en)	2003-08-07

Family

ID=22616383

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200203628A ZA200203628B (en)	1999-12-08	2002-05-07	Method for the stereoselective synthesis of cyclic amino acids.

Country Status (24)

Country	Link
EP (1)	EP1237847B1 (ko)
JP (1)	JP2003516378A (ko)
KR (1)	KR20020060988A (ko)
CN (2)	CN1607201A (ko)
AR (1)	AR032433A1 (ko)
AT (1)	ATE326443T1 (ko)
AU (1)	AU1808401A (ko)
BR (1)	BR0016201A (ko)
CA (1)	CA2392761A1 (ko)
CO (1)	CO5280085A1 (ko)
DE (1)	DE60028076T2 (ko)
DK (1)	DK1237847T3 (ko)
EA (1)	EA004984B1 (ko)
ES (1)	ES2264424T3 (ko)
HU (1)	HUP0203812A3 (ko)
IL (1)	IL149575A0 (ko)
MX (1)	MXPA02004829A (ko)
PE (1)	PE20010927A1 (ko)
PL (1)	PL355787A1 (ko)
PT (1)	PT1237847E (ko)
UY (1)	UY26475A1 (ko)
WO (1)	WO2001042190A1 (ko)
YU (1)	YU41602A (ko)
ZA (1)	ZA200203628B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0111913A (pt) *	2000-06-26	2004-01-06	Warner Lambert Co	Análogos de gabapentina para distúrbios do sono
AR031473A1 (es) *	2000-11-20	2003-09-24	Lundbeck & Co As H	Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide
US6818787B2 (en)	2001-06-11	2004-11-16	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en)	2005-04-06	2011-11-01	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en)	2001-06-11	2007-03-06	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
KR100709159B1 (ko) *	2002-12-13	2007-04-19	워너-램버트 캄파니 엘엘씨	섬유근육통 및 기타 관련 장애를 위한 가바펜틴 유사체
CN101515737B (zh) *	2008-02-20	2010-10-06	中国科学院工程热物理研究所	应用三甲基叠氮硅烷为发电机定子蒸发冷却介质的方法
CN102557922A (zh) *	2010-12-20	2012-07-11	上海药明康德新药开发有限公司	顺式-3-羟基-3-甲基环丁基甲酸的合成方法
DE102010055499A1 (de) *	2010-12-22	2011-06-16	W.C. Heraeus Gmbh	Prozess zur Herstellung von Bendamustinalkylester, Bendarmustin sowie Derivaten davon
CN102249833B (zh) *	2011-05-27	2013-12-11	中国科学院化学研究所	一种制备手性γ-氨基酸及其衍生物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100589066B1 (ko) *	1997-10-27	2006-06-13	워너-램버트 캄파니 엘엘씨	약제로서 유용한 시클릭 아미노산 및 그의 유도체

2000
- 2000-11-30 EA EA200200463A patent/EA004984B1/ru not_active IP Right Cessation
- 2000-11-30 DK DK00980881T patent/DK1237847T3/da active
- 2000-11-30 CN CNA2004100628430A patent/CN1607201A/zh active Pending
- 2000-11-30 DE DE60028076T patent/DE60028076T2/de not_active Expired - Fee Related
- 2000-11-30 AT AT00980881T patent/ATE326443T1/de not_active IP Right Cessation
- 2000-11-30 PT PT00980881T patent/PT1237847E/pt unknown
- 2000-11-30 EP EP00980881A patent/EP1237847B1/en not_active Expired - Lifetime
- 2000-11-30 CA CA002392761A patent/CA2392761A1/en not_active Abandoned
- 2000-11-30 MX MXPA02004829A patent/MXPA02004829A/es not_active Application Discontinuation
- 2000-11-30 CN CN00816813A patent/CN1407967A/zh active Pending
- 2000-11-30 BR BR0016201-9A patent/BR0016201A/pt not_active IP Right Cessation
- 2000-11-30 YU YU41602A patent/YU41602A/sh unknown
- 2000-11-30 ES ES00980881T patent/ES2264424T3/es not_active Expired - Lifetime
- 2000-11-30 KR KR1020027007280A patent/KR20020060988A/ko not_active Application Discontinuation
- 2000-11-30 PL PL00355787A patent/PL355787A1/xx not_active Application Discontinuation
- 2000-11-30 AU AU18084/01A patent/AU1808401A/en not_active Abandoned
- 2000-11-30 HU HU0203812A patent/HUP0203812A3/hu unknown
- 2000-11-30 JP JP2001543492A patent/JP2003516378A/ja active Pending
- 2000-11-30 IL IL14957500A patent/IL149575A0/xx unknown
- 2000-11-30 WO PCT/US2000/032570 patent/WO2001042190A1/en not_active Application Discontinuation
- 2000-12-07 PE PE2000001314A patent/PE20010927A1/es not_active Application Discontinuation
- 2000-12-07 CO CO00093678A patent/CO5280085A1/es not_active Application Discontinuation
- 2000-12-07 AR ARP000106492A patent/AR032433A1/es unknown
- 2000-12-07 UY UY26475A patent/UY26475A1/es not_active Application Discontinuation
2002
- 2002-05-07 ZA ZA200203628A patent/ZA200203628B/en unknown

Also Published As

Publication number	Publication date
CO5280085A1 (es)	2003-05-30
ES2264424T3 (es)	2007-01-01
UY26475A1 (es)	2001-01-31
EA200200463A1 (ru)	2002-12-26
ATE326443T1 (de)	2006-06-15
KR20020060988A (ko)	2002-07-19
CN1407967A (zh)	2003-04-02
JP2003516378A (ja)	2003-05-13
PL355787A1 (en)	2004-05-17
DE60028076D1 (de)	2006-06-22
EA004984B1 (ru)	2004-10-28
AU1808401A (en)	2001-06-18
EP1237847B1 (en)	2006-05-17
DE60028076T2 (de)	2006-11-02
DK1237847T3 (da)	2006-09-04
AR032433A1 (es)	2003-11-12
YU41602A (sh)	2005-07-19
MXPA02004829A (es)	2003-10-14
PT1237847E (pt)	2006-08-31
HUP0203812A3 (en)	2004-12-28
BR0016201A (pt)	2002-08-13
IL149575A0 (en)	2002-11-10
EP1237847A1 (en)	2002-09-11
CA2392761A1 (en)	2001-06-14
HUP0203812A2 (hu)	2003-03-28
CN1607201A (zh)	2005-04-20
PE20010927A1 (es)	2001-09-08
WO2001042190A1 (en)	2001-06-14

Publication	Publication Date	Title
KR910000234B1 (ko)	1991-01-23	시스, 엔도-2-아자비사이클로[5.3.0]데칸-3-카복실산 유도체의 제조방법
US20060004083A1 (en)	2006-01-05	Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
ZA200203628B (en)	2003-08-07	Method for the stereoselective synthesis of cyclic amino acids.
US20080167311A1 (en)	2008-07-10	Prostaglandin Prodrugs
AU2005299473B2 (en)	2012-06-28	Therapeutic and delivery methods of prostaglandin EP4 agonists
US5739160A (en)	1998-04-14	Cyclopentane- and -pentene-β-amino acids
JP5735913B2 (ja)	2015-06-17	エゼチミブを合成する方法およびこのために有用な中間体
AU2001249268A1 (en)	2001-10-03	Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
KR910001438B1 (ko)	1991-03-07	광학적 활성 비시클릭 이미노-α-카복실산 에스테르 라세미체의 분할방법
NZ228688A (en)	1992-03-26	Amides of cycloalkane-1,2-dicarboxylic acids and pharmaceutical compositions thereof
DE69813886T2 (de)	2004-01-08	Naphthalin derivate
EP1180094A1 (en)	2002-02-20	Fused polycyclic amino acids as pharmaceutical agents
US20120016155A1 (en)	2012-01-19	Diastereoisomers of hypophosphorous acid derivatives
US5631291A (en)	1997-05-20	Cyclopentane- and -pentene-β-amino acids
CA2012569A1 (en)	1990-09-22	Benzothiopyranylamines
HUT68514A (en)	1995-06-28	Phenylglycidamines of imidazolyl-methyl-substituted phenylacetic acid derivatives and pharmaceutical compositions containing them
IE48497B1 (en)	1985-02-06	Derivatives of pyrrolidinecarboxaldehyde and piperidinecarboxaldehyde and intermediates therefor
DE69226443T2 (de)	1999-02-04	N-(mercaptoacyl)aminosäure, ihre herstellung, ihre therapeutische verwendung und sie enthaltende pharmazeutische zusammensetzungen
EP1511728B1 (fr)	2007-03-14	Derives d oxophenyl-cyclohexyl-propanolamine, leur preparati on et leur application en therapeutique
AU670139B2 (en)	1996-07-04	Phenylacetic acid derivatives, process for the preparation thereof and corresponding use
PT93179A (pt)	1990-08-31	Processo para a preparacao de agentes diureticos glutaramida substituida com cicloalquilo
HUT68070A (en)	1995-05-29	Process for preparing substituted pyrrolidine derivatives and pharmaceutical compositions containing them
US20070238721A1 (en)	2007-10-11	Highly Selective Novel Amidation Method
HU215926B (hu)	1999-03-29	Eljárás optikailag aktív norbornil-amin-származékok előállítására
US6710190B1 (en)	2004-03-23	3-heteroarylalkyl substituted gaba analogs